Zacks Investment Research Upgrades Novus Therapeutics (NASDAQ:NVUS) to “Buy” - TechNewsObserver

Zacks Investment Research Upgrades Novus Therapeutics (NASDAQ:NVUS) to “Buy”  TechNewsObserver

Zacks Investment Research upgraded shares of Novus Therapeutics (NASDAQ:NVUS) from a hold rating to a buy rating in a report published on Friday morning, ...



Comments

Popular posts from this blog

Summary of Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and management of fetal growth restriction - Contemporary Obgyn

Sarcoidosis: Causes, Symptoms, Diagnosis & Treatment